Výsledky vyhledávání - "J, Koutantos"

Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study

Autor: A. Athanasiou, G.P. Stathopoulos, Achilles Anagnostopoulos, J. Koutantos, J. Dimitroulis, Dimitrios T. Trafalis

Publikováno v: Oncology Letters. 1:335-338

Erlotinib is an oral, small-molecule targeting therapy that inhibits epidermal growth factor tyrosine kinase receptors. Erlotinib has been administered for the treatment of advanced pancreatic cancer and non-small cell lung cancer. In the present tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2bbf43285c8336f486c984f9577015e
https://doi.org/10.3892/ol_00000059

Zobrazit plný text záznamu

Contents Vol. 78, 2010

Autor: Yoshiko Aoyagi, Manoop S. Bhutani, Francesco Paolo D'Armiento, Jian-Zhong Di, Maurie Markman, Hiroto Kayashima, Nikolaos Androulakis, Toshiaki Watanabe, J. Legakis, Georgia Milaki, Jørn G. Stemland, Jennifer J. Knox, Jeffrey H. Lee, Julio Hajdenberg, Alfonso De Stefano, Marcella Giordano, John V. Brown, Keisuke Nakamura, Seiji Naito, Kazuyoshi Motomura, Isao Ikemoto, Kenzo Shimazu, Anna Crispo, Tamila L. Kindwall-Keller, Norikazu Masuda, Bram H. Goldstein, Kenichi Taguchi, Hajime Shibuya, J. Koutantos, Carsten Nieder, Eric M. Rohren, Brendan D. Curti, Yoshihisa Sakaguchi, J. Stathopoulos, Maria D'Armiento, John D. Hainsworth, Taiji Tsukamoto, Jodi J. Prochaska, S. Batzios, Pin Zhang, Ronald M. Bukowski, Hiroshi Yamamoto, Yuichi Takatsuka, Harry A. Drabkin, Qi Zheng, Ai-Zhong Wang, Eisuke Adachi, David F. McDermott, Mikio Namiki, Niki Karachaliou, Zhongxing Liao, Hideo Inaji, Sabino De Placido, Santosh B. Murthy, Chenghua Xia, Nikolaos Vardakis, Lisa N. Abaid, D. Trafalis, Mark Kozloff, Srikrishna V. Patnana, Christopher W. Ryan, Tetsuya Taguchi, Stephen G. Swisher, Yasushi Toh, Janice P. Dutcher, Fumine Tsukamoto, Nikolaos Ziras, Yu Wang, Wayne L. Hofstetter, Astrid Dalhaug, Yoshihiko Maehara, Wilson H. Miller, Lianchun Xiao, John P. Micha, Takeshi Okamura, Homer A. Macapinlac, Hiroyuki Fujimoto, Jaffer A. Ajani, Kazuyuki Wakita, Stefano Pepe, A. Armakolas, Fairooz F. Kabbinavar, Shinzaburo Noguchi, Axel Grothey, Michiyuki Usami, Wei Dong, Guanshan Zhu, Xuemei Wang, Takahiro Nakayama, Jordan Berlin, Wen-Ye Gu, Robert A. Figlin, Lisa Cupit, Jan Norum, Luis Chu, G.P. Stathopoulos, Vassilis Georgoulias, Lifang Hou, Hisae Iinuma, Kohri Yoneda, Akinobu Taketomi, Ken Shirabe, Antonia Kalykaki, Zhong-Zheng Zhu, Sarita Dubey, Charles A. Henderson, L. Cannella, Mark A. Rettenmaier, Mark Ashby, Amy P. Sing, Norifumi Harimoto, Janine K. Cataldo, Takashi Nomura, Marc S. Ernstoff, Walter M. Stadler, Takashi Morimoto, Andrew J. Gawron, Wen-Ming Cong, Aris Polyzos, Nikolaos Kentepozidis, Patrick J. Flynn, Chiara Carlomagno, Hideyuki Akaza, Mikio Kobayashi, C. Batziou, Stylianos Kakolyris, Sebastien J. Hotte, Yoshiaki Nakano

Publikováno v: Oncology. 78:I-IV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a845939c0959cb1a673f74e2c72375cb
https://doi.org/10.1159/000321101

Zobrazit plný text záznamu

Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study

Autor: J. Stathopoulos, J. Legakis, S. Batzios, Dimitrios T. Trafalis, C. Batziou, Athanasios Armakolas, J. Koutantos, George P. Stathopoulos

Publikováno v: Oncology. 78:376-381

Objective: The objective of this phase III trial was to compare chemotherapy combined with bevacizumab versus chemotherapy alone in the treatment of patients with advanced colorectal cancer. Methods: From September 2004 till September 2008, 222 treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5cd2e17639dcb3aece068007d6ce1c4
https://doi.org/10.1159/000320520

Zobrazit plný text záznamu

Maintenance chemotherapy or not in ovarian cancer stages IIIA, B, C, and IV after disease recurrence

Autor: G P, Stathopoulos, Ch, Papadimitriou, G, Aravantinos, S K, Rigatos, N, Malamos, J G, Stathopoulos, M, Kaparelou, J, Koutantos, Ch, Andreadis

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 17(4)

Ovarian cancer may have a high percentage of residual disease after chemotherapy. It is questionable whether second or more lines of chemotherapy are needed in patients with slow-growing residual disease. In the present trial we compared the median s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::29848190cc83a1c7d9c39e2c00baaa03
https://pubmed.ncbi.nlm.nih.gov/23335534

Zobrazit plný text záznamu

Long-term survival of patients with carcinoid tumor and liver metastases

Autor: G P, Stathopoulos, G, Papadopoulos, J, Koutantos

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 14(4)

To determine long-term survival and long-term stable disease in patients with atypical carcinoid tumor with liver metastases.From 1993 till 2008, the records of 56 patients with atypical carcinoid were reviewed. Nine of them who had liver metastases

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7d6474e48cea1300fe51f8bdc2be87f7
https://pubmed.ncbi.nlm.nih.gov/20148450

Zobrazit plný text záznamu

Lung carcinoid tumor biology: treatment and survival

Autor: J, Dahabreh, G P, Stathopoulos, J, Koutantos, S, Rigatos

Publikováno v: Oncology reports. 21(3)

A carcinoid tumor is a rare malignant disease which can be cured when localized and treated by surgery. Chemotherapy is not effective, and somatostatin is used for palliation. Rarely is the disease aggressive, and thus does not contribute to a shorte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c4a406f8bc80c28f1ae0cda6d6784bbb
https://pubmed.ncbi.nlm.nih.gov/19212636

Zobrazit plný text záznamu

Surgical management in lung metastases from colorectal cancer

Autor: J, Dahabre, M, Vasilaki, G P, Stathopoulos, A, Kondaxis, K, Iliadis, G, Papadopoulos, J, Stathopoulos, S, Rigatos, K, Vasilikos, J, Koutantos

Publikováno v: Anticancer research. 27(6C)

Colorectal cancer is a non-aggressive slow-growing disease. Surgery is often considered for the management of metastases. Chemotherapeutical agents may offer tumor reduction but radical tumor remission can only be achieved by surgery. The aim of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a779f617d46f6e5b10c1c7b939a11d44
https://pubmed.ncbi.nlm.nih.gov/18214049

Zobrazit plný text záznamu

Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects

Autor: G P, Stathopoulos, J, Koutantos, H, Lazaki, S K, Rigatos, J, Stathopoulos, G, Deliconstantinos

Publikováno v: Anticancer research. 27(3B)

Capecitabine (Xeloda) is a fluoropyrimidine which is transformed to 5-fluorouracil (5-FU) at the tumor site. The aim of the present study was to estimate the efficacy of this agent in pretreated patients with advanced breast and colorectal cancer, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::173011de233d1f8d4db645a5ca7b3f45
https://pubmed.ncbi.nlm.nih.gov/17595791

Zobrazit plný text záznamu

Angiosarcoma of the heart: case report and review of the literature

Autor: S, Batzios, A, Michalopoulos, L, Kaklamanis, J, Stathopoulos, M, Christopoulou, J, Koutantos, G P, Stathopoulos

Publikováno v: Anticancer research. 26(6C)

Primary angiosarcoma of the heart is an extremely rare malignant disease.A 32-year-old female with primary angiosarcoma of the heart at an advanced stage with lung and bone metastases is presented. The tumor showed extensive expression of c-erb-B2 an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ba59a567e1b64dbbf9be7d4482191203
https://pubmed.ncbi.nlm.nih.gov/17214349

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání